Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”

Abdullah Kaya Department of Ophthalmology, Anittepe Military Dispensary, Ankara, TurkeyI read the current article titled “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual o...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Kaya A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	ranibizumab anti-VEGF age related macular degeneration visual acuity injection Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/4d8d321a41e24cb49dc93f2b912c04b0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:4d8d321a41e24cb49dc93f2b912c04b0
record_format	dspace
spelling	oai:doaj.org-article:4d8d321a41e24cb49dc93f2b912c04b02021-12-02T00:38:50ZComment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”1177-5483https://doaj.org/article/4d8d321a41e24cb49dc93f2b912c04b02016-04-01T00:00:00Zhttps://www.dovepress.com/comment-on-ldquothree-year-follow-up-of-ranibizumab-treatment-of-wet-a-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Abdullah Kaya Department of Ophthalmology, Anittepe Military Dispensary, Ankara, TurkeyI read the current article titled “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes” by Razi et al,1 with great interest. View the original article by Razi et alKaya ADove Medical Pressarticleranibizumabanti-VEGFage related macular degenerationvisual acuityinjectionOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2016, Iss Issue 1, Pp 695-696 (2016)
institution	DOAJ
collection	DOAJ
language	EN
topic	ranibizumab anti-VEGF age related macular degeneration visual acuity injection Ophthalmology RE1-994
spellingShingle	ranibizumab anti-VEGF age related macular degeneration visual acuity injection Ophthalmology RE1-994 Kaya A Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”
description	Abdullah Kaya Department of Ophthalmology, Anittepe Military Dispensary, Ankara, TurkeyI read the current article titled “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes” by Razi et al,1 with great interest. View the original article by Razi et al
format	article
author	Kaya A
author_facet	Kaya A
author_sort	Kaya A
title	Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”
title_short	Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”
title_full	Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”
title_fullStr	Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”
title_full_unstemmed	Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”
title_sort	comment on: “three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”
publisher	Dove Medical Press
publishDate	2016
url	https://doaj.org/article/4d8d321a41e24cb49dc93f2b912c04b0
work_keys_str_mv	AT kayaa commentonldquothreeyearfollowupofranibizumabtreatmentofwetagerelatedmaculardegenerationinfluenceofbaselinevisualacuityandinjectionfrequencyonvisualoutcomesrdquo
_version_	1718403553061502976

Comment on: &ldquo;Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes&rdquo;

Ejemplares similares

Comment on: “Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes”